AUSTIN, Texas, Oct. 06, 2026 (GLOBE NEWSWIRE) — Equity Insider News Commentary – The global market for artificial intelligence in drug discovery is projected to grow from $5.09 billion in 2026 to $17.56 billion by 2031, a compound annual growth rate of 28.1%, according to MarketsandMarkets. As that spending moves from pilots into discovery workflows, the enterprise software industry has converged on a new layer between an organization’s data and the AI agents that act on it, variously called an ontology, a semantic layer or a context layer. The open question for life sciences is whether a layer built to describe a business can also describe biology. Active Companies from around the markets with current developments this week include: MindWalk Holdings Corp. (NASDAQ: HYFT), Palantir Technologies Inc. (NASDAQ: PLTR), Snowflake Inc. (NYSE: SNOW), Microsoft Corporation (NASDAQ: MSFT), Veeva Systems Inc. (NYSE: VEEV).

Originally published via Source Article.